Literature DB >> 20233752

Serum sarcosine is not a marker for prostate cancer.

Eduard A Struys, Annemieke C Heijboer, Jeroen van Moorselaar, Cornelis Jakobs, Marinus A Blankenstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20233752     DOI： 10.1258/acb.2010.009270

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN： 0004-5632            Impact factor:   2.057


× No keyword cloud information.
  19 in total

Review 1.  Application of metabolomics to prostate cancer.

Authors:  Bruce J Trock
Journal:  Urol Oncol       Date:  2011 Sep-Oct       Impact factor: 3.498

Review 2.  Identification of aberrant pathways and network activities from high-throughput data.

Authors:  Jinlian Wang; Yuji Zhang; Catalin Marian; Habtom W Ressom
Journal:  Brief Bioinform       Date:  2012-01-27       Impact factor: 11.622

Review 3.  Review of mass spectrometry-based metabolomics in cancer research.

Authors:  David B Liesenfeld; Nina Habermann; Robert W Owen; Augustin Scalbert; Cornelia M Ulrich
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-10-04       Impact factor: 4.254

4.  Urine metabolomic analysis identifies potential biomarkers and pathogenic pathways in kidney cancer.

Authors:  Kyoungmi Kim; Sandra L Taylor; Sheila Ganti; Lining Guo; Michael V Osier; Robert H Weiss
Journal:  OMICS       Date:  2011-02-24

5.  Metabolomics: a novel approach to early and noninvasive prostate cancer detection.

Authors:  Matthew J Roberts; Horst J Schirra; Martin F Lavin; Robert A Gardiner
Journal:  Korean J Urol       Date:  2011-02-19

Review 6.  UPLC-MS for metabolomics: a giant step forward in support of pharmaceutical research.

Authors:  Ala F Nassar; Terence Wu; Samuel F Nassar; Adam V Wisnewski
Journal:  Drug Discov Today       Date:  2016-12-02       Impact factor: 7.851

Review 7.  Circulating metabolite biomarkers: a game changer in the human prostate cancer diagnosis.

Authors:  Sabareeswaran Krishnan; Shruthi Kanthaje; Devasya Rekha Punchappady; M Mujeeburahiman; Chandrahas Koumar Ratnacaram
Journal:  J Cancer Res Clin Oncol       Date:  2022-06-28       Impact factor: 4.553

8.  Prospective evaluation of serum sarcosine and risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Authors:  Stella Koutros; Tamra E Meyer; Stephen D Fox; Haleem J Issaq; Timothy D Veenstra; Wen-Yi Huang; Kai Yu; Demetrius Albanes; Lisa W Chu; Gerald Andriole; Robert N Hoover; Ann W Hsing; Sonja I Berndt
Journal:  Carcinogenesis       Date:  2013-05-22       Impact factor: 4.944

9.  Application of Holistic Liquid Chromatography-High Resolution Mass Spectrometry Based Urinary Metabolomics for Prostate Cancer Detection and Biomarker Discovery.

Authors:  Tong Zhang; David G Watson; Lijie Wang; Muhammad Abbas; Laura Murdoch; Lisa Bashford; Imran Ahmad; Nga-Yee Lam; Anthony C F Ng; Hing Y Leung
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

10.  Identification of metabolites in the normal ovary and their transformation in primary and metastatic ovarian cancer.

Authors:  Miranda Y Fong; Jonathan McDunn; Sham S Kakar
Journal:  PLoS One       Date:  2011-05-19       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.